United Therapeutics (UTHR)CEO sold ~$329K
Martine A Rothblatt, CEO at United Therapeutics, sold ~$329K of United Therapeutics shares.
- ~$329K
- Approx. value · 601 sh @ $546.94
- 330K
- Holds after · shares reported
- Traded
- Oct 15, 2026
- Filed
- Oct 16, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 14, 2026Insider · 1 personInsiders: 7 sales (~$4.7M)
- Aug 17, 2026Insider · 1 personInsiders: 7 sales (~$4.8M)
- Aug 18, 2026Insider · 1 personInsiders: 10 sales (~$4.9M)
- Aug 19, 2026Insider · 1 personInsiders: 12 sales (~$5.0M)
- Aug 20, 2026Insider · 2 peopleInsiders: 17 sales (~$9.3M)
- Aug 21, 2026Insider · 1 personInsiders: 15 sales (~$4.9M)
- Aug 24, 2026Insider · 1 personInsiders: 5 sales (~$4.9M)
- Aug 25, 2026Insider · 1 personInsiders: 6 sales (~$4.9M)
- Aug 26, 2026InsiderCEO sold ~$288K of UTHR shares in the open market
- Sep 8, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for United Therapeutics
For United Therapeutics, OQRO holds 795 insider filings (SEC Form 4 or Form 144), 17 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its UTHR page.
Other recent filings by Martine A Rothblatt, Chairperson & CEO
- SEC Form 4 at United Therapeutics (UTHR)Oct 19, 2026
- SEC Form 4 at United Therapeutics (UTHR)Oct 19, 2026
- SEC Form 4 at United Therapeutics (UTHR)Oct 19, 2026
- SEC Form 4 at United Therapeutics (UTHR)Oct 19, 2026
- SEC Form 4 at United Therapeutics (UTHR)Oct 19, 2026
The full history of Martine A Rothblatt, Chairperson & CEO is on the profile page.
How this filing works
Explore the data
Other disclosures at United Therapeutics
- SEC Form 4Oct 19, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Oct 19, 2026
Everything OQRO holds on this company is on its UTHR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
